What are flavanols and what are their health benefits?

Cocoa flavanols can improve human endothelial function within 1-2 hours, offering rapid cardiovascular benefits comparable to statins in the short term, according to Nature. These compounds enhance peripheral artery vasodilation, swiftly impacting heart health. This rapid response challenges the common perception that low bioavailability negates the health benefits of plant compounds, suggesting even transient exposure or low concentrations are physiologically active. While many beneficial plant compounds exhibit low bioavailability, specific flavanols, particularly from cocoa, still deliver rapid and clinically significant health improvements. A complex interaction within the human body is highlighted by this paradox. Therefore, focusing on the source and processing of flavanol-rich foods is crucial for maximizing their health impact.

What Are Flavonols and Where Do They Come From?

Flavanols, a subgroup of flavonoids, are plant compounds with health-promoting properties. Raw cocoa beans are rich in primary flavanols like (−)-epicatechin (EC), ranging from 0.1 to 13.5 mg/g, and oligomeric and polymeric procyanidins (18-27 mg/g and 9-16 mg/g respectively), according to Advances Nutrition. However, processing drastically reduces these levels. In finished milk and dark chocolates, EC drops to 0.18-1.25 mg/g, oligomeric procyanidins to 1.1-11.2 mg/g, and polymeric procyanidins to 0.8-7.0 mg/g. Beyond cocoa, black tea provides the largest dietary flavanol intake, about 32% of total flavonols, according to ARS. This significant reduction in processed products means consumers often get far less than they expect.

The Bioavailability Paradox: How Flavonols Work in the Body

Cocoa flavanols, despite their rapid effects, are moderately bioavailable and undergo extensive metabolism, primarily by colonic microbiota, according to PMC.ncbi.nlm.nih.gov. The compounds circulating in the bloodstream are often transformed derivatives, not original flavanols. For example, phase II derivatives of epicatechin show kinetics compatible with small intestine absorption. Further metabolism in the colon forms abundant phase II derivatives like phenyl-γ-valerolactone and phenylvaleric acid. This intricate metabolic process, involving both small intestine and colonic microbiota, transforms flavanols into active, beneficial forms. The paradox resolves: even with extensive metabolism, these metabolites are potent enough to elicit rapid and significant physiological effects.